Back

Expanding the modified GRACE risk score to high-sensitivity troponin i: a multinational validation cohort study

30 August 2026 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Next-generation acute coronary syndromes: artificial intelligence, biomarkers, and precision risk prediction Biomarkers ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Dimitrios Delialis

Alexandra University Hospital, Athens (Greece)

6 More presentations in this session

Presentation thumbnail
The adrenomedullin system predicts cardiogenic shock in acute coronary syndromes
Miss Y. Wang (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Fully automated deep learning echocardiographic strain model for vessel‑specific detection of coronary occlusion
Doctor L. van Drunen (Trondheim, NO)
Abstract Slides Video
Presentation thumbnail
Prospective assessment of coronary microvascular function using continuous thermodilution among patients with acute coronary syndrome: early observations from the microSTREAM ACS study
Doctor A. Babu (Perth, AU)
Abstract Slides Video
Presentation thumbnail
Adiponectin predicts MACE in older patients with an acute coronary event and augments endothelial tissue factor activity in senescent cells
Doctor A. Tirandi (Schlieren, CH)
Abstract Slides Video
Presentation thumbnail
Biological mechanisms underlying the cardiovascular effects of branch-chain amino acids: a proteome-wide mendelian randomisation study
Doctor J. Zhao (Hong Kong, HK)
Abstract Slides Video

Access the full session

Session thumbnail
Next-generation acute coronary syndromes: artificial intelligence, biomarkers, and precision risk prediction

The Event

Event poster

ESC Congress 2026

30 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
The value of GRACE risk score for predicting mortality in heart failure patients admitted with Non ST elevation Acute Coronary Syndrome
29 June 2021
thumbnail
Congress Presentation
Troponin as risk stratification tool in CVD prevention: practical recommendations
14 April 2023
thumbnail
Congress Presentation
Validation of the European SCORE2 algorithm in four European and non-European cohort studies with contrasting populations
3 April 2025
thumbnail
Congress Presentation
High plasma levels of soluble LOX-1 portends poor survival in acute coronary syndromes beyond GRACE 2.0: A multicentre prospective cohort study
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources